Shenzhen - Delayed Quote • CNY
Shandong Sito Bio-technology Co., Ltd. (300583.SZ)
As of 2:25 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,302,384.58
1,312,111.84
1,202,622.70
913,187.60
Cost of Revenue
1,024,835.45
1,039,302.10
937,035.16
805,582.09
Gross Profit
277,549.13
272,809.75
265,587.55
107,605.51
Operating Expense
208,954.86
189,133.43
168,527.83
187,119.78
Operating Income
68,594.27
83,676.31
97,059.72
-79,514.26
Net Non Operating Interest Income Expense
-31,835.75
-35,169.90
-28,915.76
-33,887.33
Pretax Income
66,380.51
47,910.85
54,288.71
-192,448.68
Tax Provision
-4,195.00
5,433.27
18,502.62
-2,830.89
Net Income Common Stockholders
61,831.10
41,979.29
36,205.36
-179,807.24
Basic EPS
0.50
0.24
0.21
-1.05
Diluted EPS
0.50
0.24
0.21
-1.05
Basic Average Shares
134,878.73
172,222.72
170,378.17
171,244.99
Diluted Average Shares
134,878.73
172,222.72
170,378.17
171,244.99
Total Operating Income as Reported
43,303.98
49,224.85
55,972.88
-186,157.80
Total Expenses
1,233,790.31
1,228,435.53
1,105,562.98
992,701.87
Net Income from Continuing & Discontinued Operation
61,831.10
41,979.29
36,205.36
-179,807.24
Normalized Income
63,295.33
48,486.16
46,428.62
-99,947.05
Interest Income
1,762.92
3,712.40
2,658.42
1,622.95
Interest Expense
34,918.92
36,886.03
30,210.76
33,975.42
Net Interest Income
-31,835.75
-35,169.90
-28,915.76
-33,887.33
EBIT
101,299.43
84,796.89
84,499.48
-158,473.26
EBITDA
101,299.43
248,027.33
219,946.97
-15,604.30
Reconciled Cost of Revenue
1,024,835.45
1,039,302.10
937,035.16
805,582.09
Reconciled Depreciation
--
163,230.44
135,447.49
142,868.96
Net Income from Continuing Operation Net Minority Interest
61,831.10
41,979.29
36,205.36
-179,807.24
Total Unusual Items Excluding Goodwill
-1,952.31
-7,339.16
-15,509.03
-81,052.46
Total Unusual Items
-1,952.31
-7,339.16
-15,509.03
-81,052.46
Normalized EBITDA
103,251.74
255,366.49
235,455.99
65,448.16
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-488.08
-832.29
-5,285.77
-1,192.27
12/31/2020 - 1/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
000403.SZ Pacific Shuanglin Bio-pharmacy Co., LTD
29.76
+0.24%
688075.SS Assure Tech (Hangzhou) Co., Ltd.
33.05
+0.06%
688767.SS Hangzhou Biotest Biotech Co.,Ltd.
25.10
+0.40%
688105.SS Nanjing Vazyme Biotech Co.,Ltd
25.66
+0.23%
002873.SZ Guiyang Xintian Pharmaceutical Co.,Ltd.
11.35
0.00%
603229.SS Zhejiang Ausun Pharmaceutical Co., Ltd.
10.39
+2.97%
688658.SS Youcare Pharmaceutical Group Co., Ltd.
15.60
+4.07%
300049.SZ Inner Mongolia Furui Medical Science Co., Ltd.
49.59
-2.02%
300404.SZ Boji Medical Technology Co.,Ltd.
7.28
+4.30%
300255.SZ Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
11.77
+19.98%